SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-159193
Filing Date
2024-06-11
Accepted
2024-06-11 16:44:30
Documents
13
Period of Report
2024-06-06
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d768244d8k.htm   iXBRL 8-K 30757
  Complete submission text file 0001193125-24-159193.txt   152813

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA iobt-20240606.xsd EX-101.SCH 2857
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE iobt-20240606_lab.xml EX-101.LAB 17911
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iobt-20240606_pre.xml EX-101.PRE 11239
16 EXTRACTED XBRL INSTANCE DOCUMENT d768244d8k_htm.xml XML 3616
Mailing Address OLE MAALOES VEH 3 COPENHAGEN G7 2200
Business Address OLE MAALOES VEH 3 COPENHAGEN G7 2200 4570702980
IO Biotech, Inc. (Filer) CIK: 0001865494 (see all company filings)

IRS No.: 870909276 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41008 | Film No.: 241036387
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)